The effect of Kuhuang injection for treating icteric viral hepatitis and its effect on liver function
Objective: To investigate the clinical effect of Kuhuang injection in the treatment of icteric virus hepatitis and the influence on liver function. Methods: Selected our hospital 124 cases of jaundice viral hepatitis, randomly divided into the study group (62 cases) and the control group (62 cases), two groups of patients were treated with conventional liver protection, the study group plus adjuvant therapy with Kuhuang injection, compared the clinical efficacy of the two groups. Results: After treatment, the level of TBIL, DBIL, ALT, AST, γ-GT in both two groups significantly reduced when compared with those before treatment (P<0.05); after treatment, the TBIL, DBIL, ALT, AST levels in the study group were significantly lower than those in the control group (P<0.05). After treatment, yellow sclera, body yellow, dark urine, anorexia, liver percussion pain, malaise, fatigue scores in the two groups significantly reduced when compared with those before treatment (P<0.05), scleral jaundice, body yellow, dark urine, anorexia, liver percussion pain, and lassitude integration in the study group were significantly lower than those in the control group (P<0.05). After treatment, the markedly effective rate 88.71% of the study group was significantly higher than that of the control group 72.58% (P<0.05). Conclusion: Kuhuang injection in the treatment of viral hepatitis with jaundice has significant clinical effects in patients with liver function recovery better.